Is Doxazosin Mesylate compatible with breastfeeding? Do we have alternatives for Doxazosin Mesylate?
Doxazosin Mesylate
June 4, 2016 (Very Low Risk)
It is excreted into breast milk in clinically non-significant amount possibly due to its high plasma protein binding capacity.
Until more extensive published data about this drug regarding breastfeeding are available a safer alternative drug may be used, especially during the neonatal period and/or in case of premature infants.
Alternatives
- Methyldopa (Very Low Risk)
- Enalapril (Very Low Risk)
- Metoprolol (Very Low Risk)
- Captopril (Very Low Risk)
- Hydralazine Hydrochloride (Very Low Risk)
- Nifedipine (Very Low Risk)
- Nimodipine (Very Low Risk)
- Propranolol (Very Low Risk)
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Writings
- Δοξαζοσίνη Μεθανοθειονική (Greek)
- Доксазозина Мезилат (Cyrillic)
- ドキサゾシンメシル酸塩 (Japanese)
- C23H25N5O5,CH3SO3H (Molecular formula)